This report contains information on treatment and chemoprophylaxis of influenza virus infection and provides a summary of the effectiveness and safety of antiviral treatment medications.

CDC issued a HAN to notify clinicians and CDC partners that updated CDC guidance regarding the use of Influenza Antiviral Agents and Rapid Diagnostic Tests for the 2010-2011 season is now available from the CDC website.

This page contains evaluation and capacity review tools for use by CDC international partners and collaborating countries participating in influenza surveillance, laboratory testing, and pandemic preparedness and response activities.

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that Walgreens has agreed to donate $10 million in vouchers for free flu shots to 350,000 eligible uninsured and underserved people in 15 markets across the country.

2009 Results of NIH-supported study now available

Last year, as the world prepared for a pandemic of the 2009 H1N1 influenza virus, we were reminded of the severity and unpredictability of this serious disease.

The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain.

The Centers for Disease Control and Prevention (CDC) has set aside the week of December 5-11, 2010 to observe this season’s National Influenza Vaccination Week. The week-long emphasis on flu vaccination was established to highlight the importance of continuing influenza vaccination…

Because pregnant women are at increased risk for severe disease associated with influenza infection, the American College of Obstetricians and Gynecologists and the Advisory Committee on Immunization Practices have recommended seasonal influenza vaccination for women while pregnant, regardless of trimester…

Efforts to grow the vaccine virus in cells rather than eggs are currently under way and there is consideration of the addition to influenza vaccine of immune-stimulating adjuvants to be used in certain groups of individuals.

The following guidance on the use of influenza antiviral drugs for the prevention and control of influenza during the 2010-2011 season has been submitted to the Morbidity and Mortality Weekly Report (MMWR) and will appear in that publication at a later date.

A new commentary by researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, explores the 1510 pandemic and what we have learned since then about preventing, controlling and treating influenza.